首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Stabilization of glucose in blood samples: Out with the old, in with the new
【24h】

Stabilization of glucose in blood samples: Out with the old, in with the new

机译:血液样本中葡萄糖的稳定化:旧的,新的

获取原文
获取原文并翻译 | 示例
           

摘要

Accurate measurements of plasma glucose are required for diagnosis of diabetes, particularly of gestational diabetes, for which hemoglobin A_(1c) cannot substitute for glucose measurements [1]. While laboratories have improved the measurement procedures for plasma glucose, loss of glucose from blood samples before analysis remains a threat to accuracy of results. The traditional use of sodium fluoride (NaF) alone is unsatisfactory as it does not begin to inhibit glycolysis until 90-120 min have elapsed after blood is collected [2, 3]. The failure of NaF to properly control glycolysis leads to falsely low plasma glucose concentrations and, potentially, failure to detect diabetes. By contrast, the use of blood collection tubes with a low-pH citrate buffer stops glycolysis immediately [4].
机译:糖尿病,尤其是妊娠糖尿病的诊断需要准确测量血浆葡萄糖,而血红蛋白A_(1c)不能代替血糖测量[1]。尽管实验室已经改善了血浆葡萄糖的测量程序,但分析前血液样本中的葡萄糖损失仍然威胁着结果的准确性。单独使用氟化钠(NaF)不能令人满意,因为直到收集血液后90-120分钟才开始抑制糖酵解[2,3]。 NaF无法正确控制糖酵解会导致错误的低血浆葡萄糖浓度,并可能导致无法检测到糖尿病。相比之下,使用带有低pH柠檬酸盐缓冲液的血液采集管可立即停止糖酵解[4]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号